Hannah E Salapa Selected Research

Heterogeneous Nuclear Ribonucleoprotein A1

1/2022	Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis models.
11/2021	Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells.
1/2021	A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative Disease.
1/2020	Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
1/2019	Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.
11/2018	Dysfunctional RNA binding proteins and stress granules in multiple sclerosis.
4/2016	Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis.
1/2016	Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hannah E Salapa Research Topics

Disease

11	Multiple Sclerosis 01/2022 - 01/2016
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 01/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 11/2018
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 01/2020
1	Huntington Disease (Huntington's Disease) 01/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2021
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2020
1	Neuroinflammatory Diseases 06/2020
1	Frontotemporal Dementia (Semantic Dementia) 01/2020
1	Paralysis (Palsy) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Paraplegia (Spastic Paraplegia) 04/2016

Drug/Important Bio-Agent (IBA)

8	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2022 - 01/2016
8	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2020 - 01/2016
5	AntibodiesIBA 01/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 04/2016
2	RibonucleoproteinsIBA 01/2022 - 03/2021
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2016
1	Immunodominant EpitopesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	CryptochromesIBA 03/2021
1	Biological ProductsIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	AutoantibodiesIBA 01/2016
1	AntigensIBA 01/2016
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016

Therapy/Procedure

1	Therapeutics 03/2021